Wooridul Pharmaceutical, 14.43% ↑ Amid Rising Trend in COVID-19 (Diagnostic Kits) Theme

On the 6th, the COVID-19 (diagnostic kit) theme showed strength by rising 3.10% compared to the previous day, while Wooridul Pharmaceutical, a related stock drawing attention, surged 14.43% compared to the previous day. Wooridul Pharmaceutical is known as a pharmaceutical manufacturer and seller focused on therapeutics.

[Graph] Major stock price changes in the COVID-19 (diagnostic kit) theme

According to preliminary data compiled at 12:46, foreigners have sold -139,800 shares of Wooridul Pharmaceutical, indicating a large net selling by foreign investors.

[Table] Net trading volume of foreigners and institutions (unit: 10,000 shares)

According to the analysis by Thinkpool Robo Algorithm RASSI, Wooridul Pharmaceutical’s quant financial score is 32.01 points, which is higher in growth and stability scores than the average of other stocks related to COVID-19 (diagnostic kits), ranking 14th within the theme. This indicates that compared to other stocks in the theme, Wooridul Pharmaceutical’s sales and net profit growth rates are relatively fast, and its ability to respond to domestic and international economic environment changes is also favorable.

[Table] Top stocks by financial score within the theme

※ The quant financial score is the result of Robo Algorithm’s analysis based on each company’s sales growth rate, equity growth rate, debt ratio, current ratio, ROA, ROE, and other factors.

※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.

This content was produced with the assistance of AI translation services.